Financials
- Market Capitalization 24.98 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
14.44
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 491 | INSM Insmed Incorporated - Common Stock | 121.82 USD | +2.77% | -2.14% | +24.05% | -24.83% | 26.60 B USD | ||
| 512 | ROIV Roivant Sciences Ltd. - Common Shares | 34.64 USD | -0.20% | -6.18% | +4.40% | +89.19% | 25.02 B USD | ||
| 525 | BNTX BioNTech SE - American Depositary Shares | 101.61 USD | -0.46% | -10.86% | +11.65% | +1.62% | 24.38 B USD | ||
| 571 | UTHR United Therapeutics Corporation - Common Stock | 510.38 USD | -0.99% | -1.10% | -1.14% | +21.56% | 21.89 B USD |